Treatment of cytomegalovirus disease in solid organ transplant recipients: markers of inflammation as predictors of outcome.

Rollag, Halvor

Treatment of cytomegalovirus disease in solid organ transplant recipients: markers of inflammation as predictors of outcome. [electronic resource] - Transplantation Nov 2012 - 1060-5 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial

1534-6080

10.1097/TP.0b013e31826c39de doi


Antiviral Agents--therapeutic use
Biomarkers--blood
C-Reactive Protein--metabolism
Chemokine CXCL16
Chemokines, CXC--blood
Cytomegalovirus Infections--blood
Female
Follow-Up Studies
Ganciclovir--analogs & derivatives
Humans
Inflammation--blood
Kidney Transplantation
Liver Transplantation
Male
Middle Aged
Outcome Assessment, Health Care
Postoperative Complications--blood
Predictive Value of Tests
Receptors, Scavenger--blood
Serum Amyloid P-Component--metabolism
Transplantation
Treatment Outcome
Valganciclovir
von Willebrand Factor--metabolism